Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Retatrutide is supplied as a lyophilised powder in a single sealed vial (10 mg)
They require referrals for specialists (like HMOs) but offer some out-of-network coverage (like PPOs)
As always, any medication decisions should be made with the supervision and collaboration of your physician
Low-dose tirzepatide resulted in clinically meaningful short-term weight loss and favorable metabolic effects, supporting its effectiveness and tolerability in real-world practice
In a large phase 3 obesity trial (ACHIEVE-1), orforglipron at daily doses of 3, 12 and 36 mg caused approximately: Diarrhoea: 1926% of participants (vs 9% on placebo) Nausea: 1318% (vs 2% on placebo) Constipation: 817% (vs 4% on placebo) Vomiting: 514% (vs 1% on placebo) Across multiple studies, 617% of people stopped treatment because of side effects, mostly gut-related symptoms
US$ 24.60
US$ 25.15
US$ 21.79
US$ 28.04
US$ 21.00
